NHS hit for millions by overcharging ‘scam’

Drug companies exploit loophole in the law to hike prices by as much as 2,000 per cent

Drugs companies have been accused of “highway robbery” of the NHS by using a legal loophole to push up the price of medicines in some cases by up to 2,000 per cent – at a cost to the taxpayer of tens of millions a year.

At least 15 drugs have substantially increased in price after being “flipped” from one firm to another, according to information obtained by doctors.

The legal “scam” has prompted outrage from the British Medical Association – which has warned that vital treatments risk being denied to patients if costs rise so much that the NHS can no longer afford them.

The controversial practice involves big-pharma firms selling on medicines commonly used by the NHS to businesses acting outside the Government’s price-regulation scheme. The purchasing firms are then free to mark up the prices they charge the NHS.

In one of the worst cases, the cost of an epilepsy drug prescribed to thousands of patients by the health service was increased by 24 times the original price. Meanwhile, testosterone patches given to both men and women suffering from hormone imbalances jumped from £26 per 300g to a £395 after being sold on. And the price of a medication used to treat mental-health problems such as anxiety and schizophrenia rocketed from around £4 per five millilitres to £23 – a mark-up of 607 per cent.

It is understood that at least 15 drugs currently being supplied to the NHS have seen their price tags increase substantially after being sold from one pharmaceutical firm to another.

The BMA has now called on the Government to take action to close the loophole, which is being exploited by some of the world’s biggest drug manufacturers.

They say that it could be costing the NHS and taxpayers up to an extra £100m per annum at a time when health budgets are being slashed. A motion was unanimously passed at the BMA’s annual meeting last month criticising the pharmaceutical industry for maximising their profits at the expense of patients’ access to drugs.

The Government attempts to hold down the price of drugs bought by the NHS through the Pharmaceutical Price Regulation Scheme (PPRS), under which the Department of Health negotiates what it considers a fair price for a patented medicine.

But increasingly, some large drug manufacturers are legally over-riding this arrangement through a loophole that allows them to sell the marketing rights to a treatment when its patent expires. The buyer is then able to rebrand the drug under a new name and sell it back to the NHS in a generic form at a vastly inflated price because it no longer falls under the PPRS agreement.

Dr Peter Holden, a senior member of the BMA, said: “This is the drug companies flipping the drugs over to another firm for personal gain and milking the NHS for more money. But the patient is also being inconvenienced because we may have to find another treatment.”

The biggest worries centre on the sale of the epilepsy drug Epanutin by its manufacturer Pfizer to another business, Flynn Pharma.

The medication, which is used by around 100,000 people across Britain, originally cost about 67p per 50mg. But after the sale this price shot up to almost £16 for the same amount, representing a 2,385 per cent increase.

It was estimated that this mark-up will force the NHS to spend an extra £50m per year on Epanutin – now renamed Phenytoin.

Dr Bill Beeby, chairman of the BMA’s clinical and prescribing committee, said companies such as Pfizer – one of the planet’s largest pharmaceutical firms, worth around £44bn – and the much smaller Flynn Pharma were committing “highway robbery”, although their actions are entirely legal. He said: “The epilepsy drug is particularly bad because it involves huge numbers of patients. We’re talking about thousands across the country. There are large numbers of patients who are stabilised on the epilepsy treatment and the effect of withdrawing it could be catastrophic.”

He added: “What the manufacturer has done is totally legal but you have to question what we define as legal.”

Sue Sharpe, chief executive of the pharmaceutical services negotiating committee which represents pharmacists, said: “We believe questions should be asked of manufacturers to explain significant price increases.”

The Department of Health said systems were in place to control the price the NHS pays for “most medicines”. But a spokeswoman admitted: “Some medicines fall outside these systems and we are working to see how the NHS can get a better deal on these products.”

A Pfizer spokesman said: “Medicine divestment can play a valuable role in ensuring that a medicine continues to be available to patients.

“In the case of Phenytoin Sodium Flynn Hard Capsules, since Pfizer does not hold the UK marketing authorisation and the rights to market and distribute this product in the UK, it is not appropriate for us to talk about this medicine or comment on another company’s pricing strategy.”

David Walters, director of Flynn Pharma, said: “I fully understand that any price increase is not good news for the NHS, but had we not managed to maintain Phenytoin capsules on the market, which would not have been possible at the old price, patients would have had to switch to other, more expensive formulations.”

He also insisted the drug was “competitively priced”.

News
Patrick Stewart in the classiest ice bucket to date
people
News
Australian rapper Iggy Azalea was left red faced but, thankfully, unhurt after taking a few too many steps backwards, sending her tumbling off the stage.
peopleIggy Azalea was left red faced but apparently unhurt after taking a few too many steps backwards
News
newsComedian Lee Hurst started trend with first tweet using the hashtag
News
The current recommendation from Britain's Chief Medical Officer, is that people refrain from drinking on at least two days a week
food + drinkTheory is that hangovers are caused by methanol poisoning
PROMOTED VIDEO
Have you tried new the Independent Digital Edition apps?
News
ebooksAn evocation of the conflict through the eyes of those who lived through it
Life and Style
A nearly completed RoboThespian robot inside the Engineered Arts workshop is tested in Penryn, England. The Cornish company, operating from an industrial unit near Falmouth, is the world's only maker of commercially available life sized humanoid robots
techSuper-intelligent robots could decide destroying the human race is the kindest thing to do
News
scienceExcitement from alien hunters at 'evidence' of extraterrestrial life
News
newsRyan Crighton goes in search of the capo dei capi
Life and Style
techConcept would see planes coated in layer of micro-sensors and able to sense wear and tear
Life and Style
Customers can get their caffeine fix on the move
food + drink
Extras
indybest

Arts and Entertainment
Actors front row from left, Jared Leto, Jennifer Lawrence, Meryl Streep, Ellen DeGeneres, Bradley Cooper, Peter Nyongío Jr., and, second row, from left, Channing Tatum, Julia Roberts, Kevin Spacey, Brad Pitt, Lupita Nyongío and Angelina Jolie as they pose for a
film
Sport
sport
Life and Style
techCould new invention save millions in healthcare bills?
Sport
David Moyes gets soaked
sport Moyes becomes latest manager to take part in the ALS challenge
Voices
A meteor streaks across the sky during the Perseid Meteor Shower at a wind farm near Bogdanci, south of Skopje, Macedonia, in the early hours of 13 August
voicesHagel and Dempsey were pure Hollywood. They only needed Tom Cruise, says Robert Fisk
Independent
Travel Shop
the manor
Up to 70% off luxury travel
on city breaks Find out more
santorini
Up to 70% off luxury travel
on chic beach resorts Find out more
sardina foodie
Up to 70% off luxury travel
on country retreats Find out more
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Software Developer (Java /C# Programmer)- London

£30000 - £45000 per annum: Harrington Starr: A global investment management fi...

Senior Network Engineer-(CCIE, CCNP, Cisco, London)

£65000 - £75000 per annum: Harrington Starr: Senior Network Engineer-(CCIE, CC...

Senior Network Analyst - (CCIE, Cisco, CISSP)

£70000 - £80000 per annum: Harrington Starr: Senior Network Analyst - (CCIE, C...

Senior Network Engineer-(Design, Implementation, CCIE)

£60000 - £80000 per annum: Harrington Starr: Senior Network Engineer-(Design, ...

Day In a Page

All this talk of an ‘apocalyptic’ threat is simply childish

Robert Fisk: All this talk of an ‘apocalyptic’ threat is simply childish

Chuck Hagel and Martin Dempsey were pure Hollywood. They only needed Tom Cruise
Mafia Dons: is the Camorra in control of the Granite City?

Mafia Dons: is the Camorra in control of the Granite City?

So claims an EU report which points to the Italian Mob’s alleged grip on everything from public works to property
Emmys look set to overhaul the Oscars as Hollywood’s prize draw

Emmys look set to overhaul the Oscars as Hollywood’s prize draw

Once the poor relation, the awards show now has the top stars and boasts the best drama
What happens to African migrants once they land in Italy during the summer?

What happens to migrants once they land in Italy?

Memphis Barker follows their trail through southern Europe
French connection: After 1,300 years, there’s a bridge to Mont Saint-Michel

French connection: After 1,300 years, there’s a bridge to Mont Saint-Michel

The ugly causeway is being dismantled, an elegant connection erected in its place. So everyone’s happy, right?
Frank Mugisha: Uganda's most outspoken gay rights activist on changing people's attitudes, coming out, and the threat of being attacked

Frank Mugisha: 'Coming out was a gradual process '

Uganda's most outspoken gay rights activist on changing people's attitudes, coming out, and the threat of being attacked
Radio 1 to hire 'YouTube-famous' vloggers to broadcast online

Radio 1’s new top ten

The ‘vloggers’ signed up to find twentysomething audience
David Abraham: Big ideas for the small screen

David Abraham: Big ideas for the small screen

A blistering attack on US influence on British television has lifted the savvy head of Channel 4 out of the shadows
Florence Knight's perfect picnic: Make the most of summer's last Bank Holiday weekend

Florence Knight's perfect picnic

Polpetto's head chef shares her favourite recipes from Iced Earl Grey tea to baked peaches, mascarpone & brown sugar meringues...
Horst P Horst: The fashion photography genius who inspired Madonna comes to the V&A

Horst P Horst comes to the V&A

The London's museum has delved into its archives to stage a far-reaching retrospective celebrating the photographer's six decades of creativity
Mark Hix recipes: Try our chef's summery soups for a real seasonal refresher

Mark Hix's summery soups

Soup isn’t just about comforting broths and steaming hot bowls...
Tim Sherwood column: 'It started as a three-horse race but turned into the Grand National'

Tim Sherwood column

I would have taken the Crystal Palace job if I’d been offered it soon after my interview... but the whole process dragged on so I had to pull out
Eden Hazard: Young, gifted... not yet perfect

Eden Hazard: Young, gifted... not yet perfect

Eden Hazard admits he is still below the level of Ronaldo and Messi but, after a breakthrough season, is ready to thrill Chelsea’s fans
Tim Howard: I’m an old dog. I don’t get too excited

Tim Howard: I’m an old dog. I don’t get too excited

The Everton and US goalkeeper was such a star at the World Cup that the President phoned to congratulate him... not that he knows what the fuss is all about
Match of the Day at 50: Show reminds us that even the most revered BBC institution may have a finite lifespan – thanks to the opposition

Tom Peck on Match of the Day at 50

The show reminds us that even the most revered BBC institution may have a finite lifespan – thanks to the opposition